CHLORHEXIDINE GLUCONATE MOUTHSPRAY

14ml of solution per actuation) twice daily (once in the morning and once in the evening). Method of administration The spray should be directed inside the mouth onto the dental and gingival surfaces. For the treatment of gingivitis, a course of about one-month is advisable, although some variation in response is to be expected.

Irritative skin reactions to chlorhexidine can occur occasionally. Generalised allergic reactions to chlorhexidine have also been reported but are extremely rare. A superficial discoloration of the dorsum of the tongue may occur. This disappears after treatment is discontinued.

Discoloration of the teeth and silicate or composite restorations may also occur. This stain is not permanent and can largely be prevented by brushing with a conventional toothpaste daily before using this spray. However, in certain cases, a professional prophylaxis (scaling and polishing) may be required to remove this stain completely.

Stained anterior tooth-coloured restorations with poor margins or rough surfaces which are not adequately cleaned by professional prophylaxis may require replacement. Similarly where normal tooth brushing is not possible, as for example with intermaxillary fixation, or with extensive orthodontic appliances, scaling and polishing may also be required once the underlying conditions have been resolved.

Transient disturbances of taste sensation and a burning sensation of the tongue may occur on initial use of the spray. These effects usually diminish with continued use. Oral paraesthesia /hypoaesthesia may also occur with chlorhexidine use.

In cases where oral desquamation occurs it may be necessary to discontinue treatment. Very occasionally, swelling of the parotid glands during use of oral chlorhexidine has been reported. In all cases spontaneous resolution has occurred on discontinuing treatment.

Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

For oral use only. Do not swallow. Expel from the mouth after each use. Keep away from the eyes and ears. If the spray comes into contact with the eyes, wash out well with water. Keep out of reach and sight of children. This medicinal product contains small amounts of ethanol (alcohol), less than 100 mg per spray.

02 mg of sorbitol in each spray. The additive effect of concomitantly administered products containing sorbitol (or fructose) and dietary intake of sorbitol (or fructose) should be taken into account. The content of sorbitol in medicinal products for oral use may affect the bioavailability of other medicinal products for oral use administered concomitantly.

1.